Uppsala 2018-01-16 OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced that it has established a US subsidiary and made initial key recruitments.
OssDsign is active on the US neurosurgical implants market with its lead product OSSDSIGN Cranial PSI, a calcium-phosphate based implant for cranioplasty. Since March 2017, OssDsign has a commercial partnership with California-based Matador Medical Inc who acts as master distributor of OSSDSIGN Cranial in the US.
Following a successful introduction of OSSDSIGN Cranial PSI on the US market, OssDsign has now executed the second step in its plans for the US, including the establishment of a wholly owned US subsidiary and the recruitment of key personnel. The strategic recruitments include Jim Marchesi and Peter Grimwade, both with extensive careers within neurosurgical devices. Their specific roles have been created in order to support clinical activities and strengthen the OssDsign brand in prioritized regions of the US.
“We are pleased to see that our efforts on our most important market are working out as planned.” Says Anders Lundqvist, CEO of OssDsign. “Our strategy to work with Matador as master distributor has provided us with an initial market presence. We are now ready to execute the second step of our plan to further strengthen our US presence and accelerate our commercial efforts. The skilled and motivated team we are putting in place will work alongside Matador to increase the penetration of OSSDSIGN Cranial in key clinics in the US as well as prepare the market for future innovative product launches.”
For further information, please contact:
Anders Lundqvist, CEO, OssDsign AB
Phone: +46 73 206 98 08, email: email@example.com
OssDsign is a Swedish medtech company dedicated to creating regenerative implants for improved healing of bone defects. OssDsign provides neurosurgeons and reconstructive plastic surgeons around the world with an expanding range of innovative implant solutions for improved patient outcomes.
By combining clinical insight with proprietary material technology and patient-adapted design, OssDsign supplies an expanding range of tailored solutions for cranial repair and facial bone reconstruction. OssDsign’s technology is the result of collaboration between clinical researchers at the Karolinska University Hospital, Stockholm, and material science experts at the Ångström Laboratory at Uppsala University.
For more information: www.ossdsign.com
About OSSDSIGN® Cranial
OSSDSIGN Cranial PSI is a patient specific implant intended for the reconstruction of cranial defects. It is indicated for non-load bearing applications for patients in whom cranial growth is complete, and for use with an intact dura, with or without duraplasty. The implant is made from a proprietary calcium phosphate formulation which is reinforced by a 3D printed titanium skeleton.